Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-041712
Filing Date
2025-05-12
Accepted
2025-05-12 07:00:07
Documents
3
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0241707-6k_tiziana.htm 6-K 17078
2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED MAY 12, 2025 ea024170701ex99-1_tiziana.htm EX-99.1 6870
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6064
  Complete submission text file 0001213900-25-041712.txt   33616
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 25932529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)